SY — So-Young International Share News
0.000.00%
Last trade - 00:00- $193.73m
- $110.48m
- CNY1.52bn
Brief: Hookipa Announces Positive Phase 2 Interim Safety, Immunogenicity, And Efficacy Data For Its Cytomegalovirus Vaccine Candidate Hb-101
U.S. STOCKS ON THE MOVE-AnPac, MMTEC, Elys Game Technology, WidePoint Corp, Slack Technologies
U.S. STOCKS ON THE MOVE-Anpac, Weidai, Sunnova, Gap Inc, Frontline
So Young Intl Inc: Rises on Q4 revenue forecast
Brief: So-Young International Says Q3 Revenue Rose 18.9 Percent To RMB 359.6 Million
Brief: Hookipa Pharma Reports Third Quarter 2020 Financial Results And Provides A Corporate Update
U.S. RESEARCH ROUNDUP- Builders Firstsource, General Mills, Surface Oncology
Brief: So-Young Reports Qtrly Net Income Per Share RMB 0.03
Brief: Hookipa Pharma Q2 Revenue $6.7 Million Versus $4.1 Million
Brief: Hookipa Announces Positive Phase 2 Results For Cmv Vaccine Candidate Hb‑101
Brief: Hookipa Says Board Of Directors Will Consist Of Eight Members
Brief: Hookipa Announces FDA Clearance Of Ind Application For Hb-202/201 Clinical Trial To Treat Hpv-Positive Cancers
JD stock sale helps illuminate China’s have-nots
U.S. RESEARCH ROUNDUP- Mallinckrodt, Oric Pharmaceuticals, Therapeuticsmd
Brief: So-Young International Sees Q2 2020 Revenue Up 12.3 To 22.8 Percent
Brief: Hookipa Pharma Reports Quarterly Loss Per Share Of 43 Cents
Brief: So-Young International Reports Quarterly Average Mobile MAUs Were 3.67 Million
Brief: Hookipa Pharma Reports Q4 Loss Per Share Of $0.40
Brief: Hookipa Says First Patient Dosed In Phase 1/2 Clinical Trial For HB-201